Robert F. Apple, President & CEO at ANTARES PHARMA, INC. (ATRS), sold 425,048 shares at $4.68 ($2.0M) on 2019-12-09, disclosed to the SEC on 2019-12-11.
Open-market sale of $2.0M ATRS by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.58 | 110,000 | $503K | 25.4% |
| 2 | $4.62 | 97,000 | $448K | 22.6% |
| 3 | $4.68 | 100,000 | $468K | 23.6% |
| 4 | $4.75 | 1,000 | $5K | 0.2% |
| 5 | $4.76 | 58,524 | $278K | 14.0% |
| 6 | $4.76 | 58,524 |
| $279K |
| 14.1% |
| Total | $4.66 avg | 425,048 | $2.0M | 100% |
| Filing → |
| ATRS | SELL | 2018-08-23 | $161K | — | Filing → |
| ATRS | SELL | 2017-04-05 | $120K | — | Filing → |
| ATRS | BUY | 2016-03-18 | $43K | — | Filing → |